Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Now for something a little different
View:
Post by retiredcop on Sep 15, 2021 10:06pm

Now for something a little different

https://themarketherald.ca/promis-neurosciences-to-present-at-the-second-annual-undruggable-leaders-forum-september-15-16-2021-2021-09-15/
Comment by DavidKingCanada on Sep 16, 2021 9:01am
When will a Chinese Company Buy out Promis? Better be by Years End otherwise with so many Diluted Shares we are not going anywhere anytime soon. 
Comment by M101 on Sep 16, 2021 1:21pm
Seems like an ad bought just to say they'll be posting another conference presentation link soon.  What's different? 
Comment by JackRedwood on Sep 16, 2021 3:12pm
Would also like to know what's different this time? SP is tanking as we speak. Once aducanumab was approved we saw the SP go up to 0.285 Cad. Hopefully won't fall any further unless we get some sort of GOOD news and not some conference (Yes I know this is vital). What happened to the Serology Test for Covid19 Testing? It seems we missed the train on that one. Whats next for promis? Finding ...more  
Comment by G1945V on Sep 17, 2021 9:03am
And at this rate, if they don't announce something of substance we can easily head back to $0.08 we saw last December 2020.  They simply need to announce a start to Phase 1. The status quo is not working. jmo G1945V
Comment by M101 on Sep 17, 2021 10:17am
That's what they're telling Biden, the status quo is not working so let's heat up the cold war with China. We're here for a good time, not a long time. 
Comment by Thenorth1990 on Sep 17, 2021 3:49pm
I believe. 08 was a result of aducanumab getting a thumbs down from the fda panel and uncertainty on funding. That is not there anymore. So won't be that bad . Still might see Lower sp if no further developments. Can't believe they can get away with not keeping us in loop about serology developments so far.
Comment by Speyeder999 on Sep 17, 2021 4:38pm
I fully agree.  Despite any confdentiality agreement they may have with BC Neuroimmunology to withold any developpements regarding this matter, I can't possibly see how publicizing any progress for their ''best in class serology test'' joint effort can hinder Promis' credentials in the scientific field, if not only to solidify it. I humour myself into believing there ...more  
Comment by retiredcop on Sep 17, 2021 8:11pm
Lets think about why they aren't saying anything about the serology test and two sites that intend to use the test  keep referencing that the test is coming soon.   What could possibly be the reason.?
Comment by WriteOrRong on Sep 17, 2021 8:44pm
This post has been removed in accordance with Community Policy
Comment by JackRedwood on Sep 18, 2021 1:34pm
It's been halted twice this Year.  Buy out would be anywhere north of 500 Million meaning the SP should be over a Dollar. Thats my Sell Point.
Comment by JackRedwood on Sep 18, 2021 3:00pm
  What do you think it means Retiredcop? 
Comment by retiredcop on Sep 18, 2021 6:48pm
Govt Approval ? 
Comment by Thenorth1990 on Sep 18, 2021 6:50pm
Rc but to counter your point, forget Immusafe, how can they try to commercialize something which is not ready, that too for institutional use ? All I am saying is it's important to provide updates to keep investor confidence atleast for retail Investors who doesn't have access to much info. Nobody is forcing a news release, all we ask is to stick to their own deadlines or don't give ...more  
Comment by Speyeder999 on Sep 19, 2021 9:34am
We'll said. And if that's the case,( waiting for gov't) approval, can someone please explain how Immusafe can sell their serology tests without any gov't approval?  i recall Eliott  mentioning that although certain information could not be divulged, info regarding regulatory approvals WOULD be provided.
Comment by JackRedwood on Sep 19, 2021 9:44am
Great point, datametrix was another Company that had Covid 19 Serology Test and were selling it during the Pandemic. Not sure about now but there SP did not increase. 
Comment by DavidKingCanada on Sep 19, 2021 9:47am
There won't be any use for PMN to release any sort of Serology Test whether for Covid or not. Let's keep in mind there will be a New CEO hopefully by Years End. I am hoping to see some Big Changes.
Comment by retiredcop on Sep 19, 2021 6:58pm
And while your checking on that can you find out why immunity passport can't use immusafe's tests yet 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities